PLN 75
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
Established in 2012 and headquartered in Warsaw, Poland, Medinice S.A. specializes in delivering advanced medical solutions for the fields of cardiology and cardiac surgery. The company actively assists scientists in the complex journey of bringing new products to market, offering comprehensive support that spans prototyping, conducting clinical trials, securing essential certifications, and overseeing product sales.
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is underpriced on P/E.
Data is available to registered users only